COVID-19 Impact on Global Translational Regenerative Medicine Market Insights, Forecast to 2026
Translational Regenerative Medicine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Translational Regenerative Medicine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Translational Regenerative Medicine market is segmented into
The Translational Regenerative Medicine market is analysed and market size information is provided by regions (countries).
The key regions covered in the Translational Regenerative Medicine market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.
Competitive Landscape and Translational Regenerative Medicine Market Share Analysis
Translational Regenerative Medicine market competitive landscape provides details and data information by manufacturers. The report offers comprehensive analysis and accurate statistics on production capacity, price, revenue of Translational Regenerative Medicine by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on production, revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue, and the production capacity, price, revenue generated in Translational Regenerative Medicine business, the date to enter into the Translational Regenerative Medicine market, Translational Regenerative Medicine product introduction, recent developments, etc.
The major vendors covered:
Segment by Type, the Translational Regenerative Medicine market is segmented into
- Stem Cell Therapy
- Tissue Engineering
- Gene Therapy
- Tissue Engineering Therapy
- Wound Healing
- Cartilage Repair
- Other
The Translational Regenerative Medicine market is analysed and market size information is provided by regions (countries).
The key regions covered in the Translational Regenerative Medicine market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.
Competitive Landscape and Translational Regenerative Medicine Market Share Analysis
Translational Regenerative Medicine market competitive landscape provides details and data information by manufacturers. The report offers comprehensive analysis and accurate statistics on production capacity, price, revenue of Translational Regenerative Medicine by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on production, revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue, and the production capacity, price, revenue generated in Translational Regenerative Medicine business, the date to enter into the Translational Regenerative Medicine market, Translational Regenerative Medicine product introduction, recent developments, etc.
The major vendors covered:
- Athersys
- Avita Medical
- AxoGen
- MEDIPOST
- NuVasive
- Astellas Pharma
- Organogenesis Holdings
- Osiris Therapeutics
- Pharmicell
- Regenerys
- Takeda Pharmaceutical
- uniQure
1 STUDY COVERAGE
1.1 Translational Regenerative Medicine Product Introduction
1.2 Key Market Segments in This Study
1.3 Key Manufacturers Covered: Ranking of Global Top Translational Regenerative Medicine Manufacturers by Revenue in 2019
1.4 Market by Type
1.4.1 Global Translational Regenerative Medicine Market Size Growth Rate by Type
1.4.2 Stem Cell Therapy
1.4.3 Tissue Engineering
1.4.4 Gene Therapy
1.5 Market by Application
1.5.1 Global Translational Regenerative Medicine Market Size Growth Rate by Application
1.5.2 Tissue Engineering Therapy
1.5.3 Wound Healing
1.5.4 Cartilage Repair
1.5.5 Other
1.6 Coronavirus Disease 2019 (Covid-19): Translational Regenerative Medicine Industry Impact
1.6.1 How the Covid-19 is Affecting the Translational Regenerative Medicine Industry
1.6.1.1 Translational Regenerative Medicine Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Translational Regenerative Medicine Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Translational Regenerative Medicine Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Translational Regenerative Medicine Market Size Estimates and Forecasts
2.1.1 Global Translational Regenerative Medicine Revenue Estimates and Forecasts 2015-2026
2.1.2 Global Translational Regenerative Medicine Production Capacity Estimates and Forecasts 2015-2026
2.1.3 Global Translational Regenerative Medicine Production Estimates and Forecasts 2015-2026
2.2 Global Translational Regenerative Medicine Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Analysis of Competitive Landscape
2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
2.3.2 Global Translational Regenerative Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.3.3 Global Translational Regenerative Medicine Manufacturers Geographical Distribution
2.4 Key Trends for Translational Regenerative Medicine Markets & Products
2.5 Primary Interviews with Key Translational Regenerative Medicine Players (Opinion Leaders)
3 MARKET SIZE BY MANUFACTURERS
3.1 Global Top Translational Regenerative Medicine Manufacturers by Production Capacity
3.1.1 Global Top Translational Regenerative Medicine Manufacturers by Production Capacity (2015-2020)
3.1.2 Global Top Translational Regenerative Medicine Manufacturers by Production (2015-2020)
3.1.3 Global Top Translational Regenerative Medicine Manufacturers Market Share by Production
3.2 Global Top Translational Regenerative Medicine Manufacturers by Revenue
3.2.1 Global Top Translational Regenerative Medicine Manufacturers by Revenue (2015-2020)
3.2.2 Global Top Translational Regenerative Medicine Manufacturers Market Share by Revenue (2015-2020)
3.2.3 Global Top 10 and Top 5 Companies by Translational Regenerative Medicine Revenue in 2019
3.3 Global Translational Regenerative Medicine Price by Manufacturers
3.4 Mergers & Acquisitions, Expansion Plans
4 TRANSLATIONAL REGENERATIVE MEDICINE PRODUCTION BY REGIONS
4.1 Global Translational Regenerative Medicine Historic Market Facts & Figures by Regions
4.1.1 Global Top Translational Regenerative Medicine Regions by Production (2015-2020)
4.1.2 Global Top Translational Regenerative Medicine Regions by Revenue (2015-2020)
4.2 North America
4.2.1 North America Translational Regenerative Medicine Production (2015-2020)
4.2.2 North America Translational Regenerative Medicine Revenue (2015-2020)
4.2.3 Key Players in North America
4.2.4 North America Translational Regenerative Medicine Import & Export (2015-2020)
4.3 Europe
4.3.1 Europe Translational Regenerative Medicine Production (2015-2020)
4.3.2 Europe Translational Regenerative Medicine Revenue (2015-2020)
4.3.3 Key Players in Europe
4.3.4 Europe Translational Regenerative Medicine Import & Export (2015-2020)
4.4 China
4.4.1 China Translational Regenerative Medicine Production (2015-2020)
4.4.2 China Translational Regenerative Medicine Revenue (2015-2020)
4.4.3 Key Players in China
4.4.4 China Translational Regenerative Medicine Import & Export (2015-2020)
4.5 Japan
4.5.1 Japan Translational Regenerative Medicine Production (2015-2020)
4.5.2 Japan Translational Regenerative Medicine Revenue (2015-2020)
4.5.3 Key Players in Japan
4.5.4 Japan Translational Regenerative Medicine Import & Export (2015-2020)
5 TRANSLATIONAL REGENERATIVE MEDICINE CONSUMPTION BY REGION
5.1 Global Top Translational Regenerative Medicine Regions by Consumption
5.1.1 Global Top Translational Regenerative Medicine Regions by Consumption (2015-2020)
5.1.2 Global Top Translational Regenerative Medicine Regions Market Share by Consumption (2015-2020)
5.2 North America
5.2.1 North America Translational Regenerative Medicine Consumption by Application
5.2.2 North America Translational Regenerative Medicine Consumption by Countries
5.2.3 U.S.
5.2.4 Canada
5.3 Europe
5.3.1 Europe Translational Regenerative Medicine Consumption by Application
5.3.2 Europe Translational Regenerative Medicine Consumption by Countries
5.3.3 Germany
5.3.4 France
5.3.5 U.K.
5.3.6 Italy
5.3.7 Russia
5.4 Asia Pacific
5.4.1 Asia Pacific Translational Regenerative Medicine Consumption by Application
5.4.2 Asia Pacific Translational Regenerative Medicine Consumption by Regions
5.4.3 China
5.4.4 Japan
5.4.5 South Korea
5.4.6 India
5.4.7 Australia
5.4.8 Taiwan
5.4.9 Indonesia
5.4.10 Thailand
5.4.11 Malaysia
5.4.12 Philippines
5.4.13 Vietnam
5.5 Central & South America
5.5.1 Central & South America Translational Regenerative Medicine Consumption by Application
5.5.2 Central & South America Translational Regenerative Medicine Consumption by Country
5.5.3 Mexico
5.5.3 Brazil
5.5.3 Argentina
5.6 Middle East and Africa
5.6.1 Middle East and Africa Translational Regenerative Medicine Consumption by Application
5.6.2 Middle East and Africa Translational Regenerative Medicine Consumption by Countries
5.6.3 Turkey
5.6.4 Saudi Arabia
5.6.5 U.A.E
6 MARKET SIZE BY TYPE (2015-2026)
6.1 Global Translational Regenerative Medicine Market Size by Type (2015-2020)
6.1.1 Global Translational Regenerative Medicine Production by Type (2015-2020)
6.1.2 Global Translational Regenerative Medicine Revenue by Type (2015-2020)
6.1.3 Translational Regenerative Medicine Price by Type (2015-2020)
6.2 Global Translational Regenerative Medicine Market Forecast by Type (2021-2026)
6.2.1 Global Translational Regenerative Medicine Production Forecast by Type (2021-2026)
6.2.2 Global Translational Regenerative Medicine Revenue Forecast by Type (2021-2026)
6.2.3 Global Translational Regenerative Medicine Price Forecast by Type (2021-2026)
6.3 Global Translational Regenerative Medicine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
7 MARKET SIZE BY APPLICATION (2015-2026)
7.2.1 Global Translational Regenerative Medicine Consumption Historic Breakdown by Application (2015-2020)
7.2.2 Global Translational Regenerative Medicine Consumption Forecast by Application (2021-2026)
8 CORPORATE PROFILES
8.1 Athersys
8.1.1 Athersys Corporation Information
8.1.2 Athersys Overview and Its Total Revenue
8.1.3 Athersys Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.1.4 Athersys Product Description
8.1.5 Athersys Recent Development
8.2 Avita Medical
8.2.1 Avita Medical Corporation Information
8.2.2 Avita Medical Overview and Its Total Revenue
8.2.3 Avita Medical Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.2.4 Avita Medical Product Description
8.2.5 Avita Medical Recent Development
8.3 AxoGen
8.3.1 AxoGen Corporation Information
8.3.2 AxoGen Overview and Its Total Revenue
8.3.3 AxoGen Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.3.4 AxoGen Product Description
8.3.5 AxoGen Recent Development
8.4 MEDIPOST
8.4.1 MEDIPOST Corporation Information
8.4.2 MEDIPOST Overview and Its Total Revenue
8.4.3 MEDIPOST Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.4.4 MEDIPOST Product Description
8.4.5 MEDIPOST Recent Development
8.5 NuVasive
8.5.1 NuVasive Corporation Information
8.5.2 NuVasive Overview and Its Total Revenue
8.5.3 NuVasive Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.5.4 NuVasive Product Description
8.5.5 NuVasive Recent Development
8.6 Astellas Pharma
8.6.1 Astellas Pharma Corporation Information
8.6.2 Astellas Pharma Overview and Its Total Revenue
8.6.3 Astellas Pharma Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.6.4 Astellas Pharma Product Description
8.6.5 Astellas Pharma Recent Development
8.7 Organogenesis Holdings
8.7.1 Organogenesis Holdings Corporation Information
8.7.2 Organogenesis Holdings Overview and Its Total Revenue
8.7.3 Organogenesis Holdings Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.7.4 Organogenesis Holdings Product Description
8.7.5 Organogenesis Holdings Recent Development
8.8 Osiris Therapeutics
8.8.1 Osiris Therapeutics Corporation Information
8.8.2 Osiris Therapeutics Overview and Its Total Revenue
8.8.3 Osiris Therapeutics Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.8.4 Osiris Therapeutics Product Description
8.8.5 Osiris Therapeutics Recent Development
8.9 Pharmicell
8.9.1 Pharmicell Corporation Information
8.9.2 Pharmicell Overview and Its Total Revenue
8.9.3 Pharmicell Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.9.4 Pharmicell Product Description
8.9.5 Pharmicell Recent Development
8.10 Regenerys
8.10.1 Regenerys Corporation Information
8.10.2 Regenerys Overview and Its Total Revenue
8.10.3 Regenerys Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.10.4 Regenerys Product Description
8.10.5 Regenerys Recent Development
8.11 Takeda Pharmaceutical
8.11.1 Takeda Pharmaceutical Corporation Information
8.11.2 Takeda Pharmaceutical Overview and Its Total Revenue
8.11.3 Takeda Pharmaceutical Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.11.4 Takeda Pharmaceutical Product Description
8.11.5 Takeda Pharmaceutical Recent Development
8.12 uniQure
8.12.1 uniQure Corporation Information
8.12.2 uniQure Overview and Its Total Revenue
8.12.3 uniQure Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.12.4 uniQure Product Description
8.12.5 uniQure Recent Development
8.13 Vericel
8.13.1 Vericel Corporation Information
8.13.2 Vericel Overview and Its Total Revenue
8.13.3 Vericel Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.13.4 Vericel Product Description
8.13.5 Vericel Recent Development
9 PRODUCTION FORECASTS BY REGIONS
9.1 Global Top Translational Regenerative Medicine Regions Forecast by Revenue (2021-2026)
9.2 Global Top Translational Regenerative Medicine Regions Forecast by Production (2021-2026)
9.3 Key Translational Regenerative Medicine Production Regions Forecast
9.3.1 North America
9.3.2 Europe
9.3.3 China
9.3.4 Japan
10 TRANSLATIONAL REGENERATIVE MEDICINE CONSUMPTION FORECAST BY REGION
10.1 Global Translational Regenerative Medicine Consumption Forecast by Region (2021-2026)
10.2 North America Translational Regenerative Medicine Consumption Forecast by Region (2021-2026)
10.3 Europe Translational Regenerative Medicine Consumption Forecast by Region (2021-2026)
10.4 Asia Pacific Translational Regenerative Medicine Consumption Forecast by Region (2021-2026)
10.5 Latin America Translational Regenerative Medicine Consumption Forecast by Region (2021-2026)
10.6 Middle East and Africa Translational Regenerative Medicine Consumption Forecast by Region (2021-2026)
11 VALUE CHAIN AND SALES CHANNELS ANALYSIS
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Translational Regenerative Medicine Sales Channels
11.2.2 Translational Regenerative Medicine Distributors
11.3 Translational Regenerative Medicine Customers
12 MARKET OPPORTUNITIES & CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Porter's Five Forces Analysis
13 KEY FINDING IN THE GLOBAL TRANSLATIONAL REGENERATIVE MEDICINE STUDY
14 APPENDIX
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
1.1 Translational Regenerative Medicine Product Introduction
1.2 Key Market Segments in This Study
1.3 Key Manufacturers Covered: Ranking of Global Top Translational Regenerative Medicine Manufacturers by Revenue in 2019
1.4 Market by Type
1.4.1 Global Translational Regenerative Medicine Market Size Growth Rate by Type
1.4.2 Stem Cell Therapy
1.4.3 Tissue Engineering
1.4.4 Gene Therapy
1.5 Market by Application
1.5.1 Global Translational Regenerative Medicine Market Size Growth Rate by Application
1.5.2 Tissue Engineering Therapy
1.5.3 Wound Healing
1.5.4 Cartilage Repair
1.5.5 Other
1.6 Coronavirus Disease 2019 (Covid-19): Translational Regenerative Medicine Industry Impact
1.6.1 How the Covid-19 is Affecting the Translational Regenerative Medicine Industry
1.6.1.1 Translational Regenerative Medicine Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Translational Regenerative Medicine Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Translational Regenerative Medicine Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Translational Regenerative Medicine Market Size Estimates and Forecasts
2.1.1 Global Translational Regenerative Medicine Revenue Estimates and Forecasts 2015-2026
2.1.2 Global Translational Regenerative Medicine Production Capacity Estimates and Forecasts 2015-2026
2.1.3 Global Translational Regenerative Medicine Production Estimates and Forecasts 2015-2026
2.2 Global Translational Regenerative Medicine Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Analysis of Competitive Landscape
2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
2.3.2 Global Translational Regenerative Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.3.3 Global Translational Regenerative Medicine Manufacturers Geographical Distribution
2.4 Key Trends for Translational Regenerative Medicine Markets & Products
2.5 Primary Interviews with Key Translational Regenerative Medicine Players (Opinion Leaders)
3 MARKET SIZE BY MANUFACTURERS
3.1 Global Top Translational Regenerative Medicine Manufacturers by Production Capacity
3.1.1 Global Top Translational Regenerative Medicine Manufacturers by Production Capacity (2015-2020)
3.1.2 Global Top Translational Regenerative Medicine Manufacturers by Production (2015-2020)
3.1.3 Global Top Translational Regenerative Medicine Manufacturers Market Share by Production
3.2 Global Top Translational Regenerative Medicine Manufacturers by Revenue
3.2.1 Global Top Translational Regenerative Medicine Manufacturers by Revenue (2015-2020)
3.2.2 Global Top Translational Regenerative Medicine Manufacturers Market Share by Revenue (2015-2020)
3.2.3 Global Top 10 and Top 5 Companies by Translational Regenerative Medicine Revenue in 2019
3.3 Global Translational Regenerative Medicine Price by Manufacturers
3.4 Mergers & Acquisitions, Expansion Plans
4 TRANSLATIONAL REGENERATIVE MEDICINE PRODUCTION BY REGIONS
4.1 Global Translational Regenerative Medicine Historic Market Facts & Figures by Regions
4.1.1 Global Top Translational Regenerative Medicine Regions by Production (2015-2020)
4.1.2 Global Top Translational Regenerative Medicine Regions by Revenue (2015-2020)
4.2 North America
4.2.1 North America Translational Regenerative Medicine Production (2015-2020)
4.2.2 North America Translational Regenerative Medicine Revenue (2015-2020)
4.2.3 Key Players in North America
4.2.4 North America Translational Regenerative Medicine Import & Export (2015-2020)
4.3 Europe
4.3.1 Europe Translational Regenerative Medicine Production (2015-2020)
4.3.2 Europe Translational Regenerative Medicine Revenue (2015-2020)
4.3.3 Key Players in Europe
4.3.4 Europe Translational Regenerative Medicine Import & Export (2015-2020)
4.4 China
4.4.1 China Translational Regenerative Medicine Production (2015-2020)
4.4.2 China Translational Regenerative Medicine Revenue (2015-2020)
4.4.3 Key Players in China
4.4.4 China Translational Regenerative Medicine Import & Export (2015-2020)
4.5 Japan
4.5.1 Japan Translational Regenerative Medicine Production (2015-2020)
4.5.2 Japan Translational Regenerative Medicine Revenue (2015-2020)
4.5.3 Key Players in Japan
4.5.4 Japan Translational Regenerative Medicine Import & Export (2015-2020)
5 TRANSLATIONAL REGENERATIVE MEDICINE CONSUMPTION BY REGION
5.1 Global Top Translational Regenerative Medicine Regions by Consumption
5.1.1 Global Top Translational Regenerative Medicine Regions by Consumption (2015-2020)
5.1.2 Global Top Translational Regenerative Medicine Regions Market Share by Consumption (2015-2020)
5.2 North America
5.2.1 North America Translational Regenerative Medicine Consumption by Application
5.2.2 North America Translational Regenerative Medicine Consumption by Countries
5.2.3 U.S.
5.2.4 Canada
5.3 Europe
5.3.1 Europe Translational Regenerative Medicine Consumption by Application
5.3.2 Europe Translational Regenerative Medicine Consumption by Countries
5.3.3 Germany
5.3.4 France
5.3.5 U.K.
5.3.6 Italy
5.3.7 Russia
5.4 Asia Pacific
5.4.1 Asia Pacific Translational Regenerative Medicine Consumption by Application
5.4.2 Asia Pacific Translational Regenerative Medicine Consumption by Regions
5.4.3 China
5.4.4 Japan
5.4.5 South Korea
5.4.6 India
5.4.7 Australia
5.4.8 Taiwan
5.4.9 Indonesia
5.4.10 Thailand
5.4.11 Malaysia
5.4.12 Philippines
5.4.13 Vietnam
5.5 Central & South America
5.5.1 Central & South America Translational Regenerative Medicine Consumption by Application
5.5.2 Central & South America Translational Regenerative Medicine Consumption by Country
5.5.3 Mexico
5.5.3 Brazil
5.5.3 Argentina
5.6 Middle East and Africa
5.6.1 Middle East and Africa Translational Regenerative Medicine Consumption by Application
5.6.2 Middle East and Africa Translational Regenerative Medicine Consumption by Countries
5.6.3 Turkey
5.6.4 Saudi Arabia
5.6.5 U.A.E
6 MARKET SIZE BY TYPE (2015-2026)
6.1 Global Translational Regenerative Medicine Market Size by Type (2015-2020)
6.1.1 Global Translational Regenerative Medicine Production by Type (2015-2020)
6.1.2 Global Translational Regenerative Medicine Revenue by Type (2015-2020)
6.1.3 Translational Regenerative Medicine Price by Type (2015-2020)
6.2 Global Translational Regenerative Medicine Market Forecast by Type (2021-2026)
6.2.1 Global Translational Regenerative Medicine Production Forecast by Type (2021-2026)
6.2.2 Global Translational Regenerative Medicine Revenue Forecast by Type (2021-2026)
6.2.3 Global Translational Regenerative Medicine Price Forecast by Type (2021-2026)
6.3 Global Translational Regenerative Medicine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
7 MARKET SIZE BY APPLICATION (2015-2026)
7.2.1 Global Translational Regenerative Medicine Consumption Historic Breakdown by Application (2015-2020)
7.2.2 Global Translational Regenerative Medicine Consumption Forecast by Application (2021-2026)
8 CORPORATE PROFILES
8.1 Athersys
8.1.1 Athersys Corporation Information
8.1.2 Athersys Overview and Its Total Revenue
8.1.3 Athersys Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.1.4 Athersys Product Description
8.1.5 Athersys Recent Development
8.2 Avita Medical
8.2.1 Avita Medical Corporation Information
8.2.2 Avita Medical Overview and Its Total Revenue
8.2.3 Avita Medical Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.2.4 Avita Medical Product Description
8.2.5 Avita Medical Recent Development
8.3 AxoGen
8.3.1 AxoGen Corporation Information
8.3.2 AxoGen Overview and Its Total Revenue
8.3.3 AxoGen Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.3.4 AxoGen Product Description
8.3.5 AxoGen Recent Development
8.4 MEDIPOST
8.4.1 MEDIPOST Corporation Information
8.4.2 MEDIPOST Overview and Its Total Revenue
8.4.3 MEDIPOST Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.4.4 MEDIPOST Product Description
8.4.5 MEDIPOST Recent Development
8.5 NuVasive
8.5.1 NuVasive Corporation Information
8.5.2 NuVasive Overview and Its Total Revenue
8.5.3 NuVasive Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.5.4 NuVasive Product Description
8.5.5 NuVasive Recent Development
8.6 Astellas Pharma
8.6.1 Astellas Pharma Corporation Information
8.6.2 Astellas Pharma Overview and Its Total Revenue
8.6.3 Astellas Pharma Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.6.4 Astellas Pharma Product Description
8.6.5 Astellas Pharma Recent Development
8.7 Organogenesis Holdings
8.7.1 Organogenesis Holdings Corporation Information
8.7.2 Organogenesis Holdings Overview and Its Total Revenue
8.7.3 Organogenesis Holdings Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.7.4 Organogenesis Holdings Product Description
8.7.5 Organogenesis Holdings Recent Development
8.8 Osiris Therapeutics
8.8.1 Osiris Therapeutics Corporation Information
8.8.2 Osiris Therapeutics Overview and Its Total Revenue
8.8.3 Osiris Therapeutics Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.8.4 Osiris Therapeutics Product Description
8.8.5 Osiris Therapeutics Recent Development
8.9 Pharmicell
8.9.1 Pharmicell Corporation Information
8.9.2 Pharmicell Overview and Its Total Revenue
8.9.3 Pharmicell Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.9.4 Pharmicell Product Description
8.9.5 Pharmicell Recent Development
8.10 Regenerys
8.10.1 Regenerys Corporation Information
8.10.2 Regenerys Overview and Its Total Revenue
8.10.3 Regenerys Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.10.4 Regenerys Product Description
8.10.5 Regenerys Recent Development
8.11 Takeda Pharmaceutical
8.11.1 Takeda Pharmaceutical Corporation Information
8.11.2 Takeda Pharmaceutical Overview and Its Total Revenue
8.11.3 Takeda Pharmaceutical Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.11.4 Takeda Pharmaceutical Product Description
8.11.5 Takeda Pharmaceutical Recent Development
8.12 uniQure
8.12.1 uniQure Corporation Information
8.12.2 uniQure Overview and Its Total Revenue
8.12.3 uniQure Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.12.4 uniQure Product Description
8.12.5 uniQure Recent Development
8.13 Vericel
8.13.1 Vericel Corporation Information
8.13.2 Vericel Overview and Its Total Revenue
8.13.3 Vericel Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.13.4 Vericel Product Description
8.13.5 Vericel Recent Development
9 PRODUCTION FORECASTS BY REGIONS
9.1 Global Top Translational Regenerative Medicine Regions Forecast by Revenue (2021-2026)
9.2 Global Top Translational Regenerative Medicine Regions Forecast by Production (2021-2026)
9.3 Key Translational Regenerative Medicine Production Regions Forecast
9.3.1 North America
9.3.2 Europe
9.3.3 China
9.3.4 Japan
10 TRANSLATIONAL REGENERATIVE MEDICINE CONSUMPTION FORECAST BY REGION
10.1 Global Translational Regenerative Medicine Consumption Forecast by Region (2021-2026)
10.2 North America Translational Regenerative Medicine Consumption Forecast by Region (2021-2026)
10.3 Europe Translational Regenerative Medicine Consumption Forecast by Region (2021-2026)
10.4 Asia Pacific Translational Regenerative Medicine Consumption Forecast by Region (2021-2026)
10.5 Latin America Translational Regenerative Medicine Consumption Forecast by Region (2021-2026)
10.6 Middle East and Africa Translational Regenerative Medicine Consumption Forecast by Region (2021-2026)
11 VALUE CHAIN AND SALES CHANNELS ANALYSIS
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Translational Regenerative Medicine Sales Channels
11.2.2 Translational Regenerative Medicine Distributors
11.3 Translational Regenerative Medicine Customers
12 MARKET OPPORTUNITIES & CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Porter's Five Forces Analysis
13 KEY FINDING IN THE GLOBAL TRANSLATIONAL REGENERATIVE MEDICINE STUDY
14 APPENDIX
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
LIST OF TABLES
Table 1. Translational Regenerative Medicine Key Market Segments in This Study
Table 2. Ranking of Global Top Translational Regenerative Medicine Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Translational Regenerative Medicine Market Size Growth Rate by Type 2020-2026 (K Units) (Million US$)
Table 4. Major Manufacturers of Stem Cell Therapy
Table 5. Major Manufacturers of Tissue Engineering
Table 6. Major Manufacturers of Gene Therapy
Table 7. COVID-19 Impact Global Market: (Four Translational Regenerative Medicine Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Translational Regenerative Medicine Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Translational Regenerative Medicine Players to Combat Covid-19 Impact
Table 12. Global Translational Regenerative Medicine Market Size Growth Rate by Application 2020-2026 (K Units)
Table 13. Global Translational Regenerative Medicine Market Size by Region in US$ Million: 2015 VS 2020 VS 2026
Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Global Translational Regenerative Medicine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Translational Regenerative Medicine as of 2019)
Table 16. Translational Regenerative Medicine Manufacturing Base Distribution and Headquarters
Table 17. Manufacturers Translational Regenerative Medicine Product Offered
Table 18. Date of Manufacturers Enter into Translational Regenerative Medicine Market
Table 19. Key Trends for Translational Regenerative Medicine Markets & Products
Table 20. Main Points Interviewed from Key Translational Regenerative Medicine Players
Table 21. Global Translational Regenerative Medicine Production Capacity by Manufacturers (2015-2020) (K Units)
Table 22. Global Translational Regenerative Medicine Production Share by Manufacturers (2015-2020)
Table 23. Translational Regenerative Medicine Revenue by Manufacturers (2015-2020) (Million US$)
Table 24. Translational Regenerative Medicine Revenue Share by Manufacturers (2015-2020)
Table 25. Translational Regenerative Medicine Price by Manufacturers 2015-2020 (USD/Unit)
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Translational Regenerative Medicine Production by Regions (2015-2020) (K Units)
Table 28. Global Translational Regenerative Medicine Production Market Share by Regions (2015-2020)
Table 29. Global Translational Regenerative Medicine Revenue by Regions (2015-2020) (US$ Million)
Table 30. Global Translational Regenerative Medicine Revenue Market Share by Regions (2015-2020)
Table 31. Key Translational Regenerative Medicine Players in North America
Table 32. Import & Export of Translational Regenerative Medicine in North America (K Units)
Table 33. Key Translational Regenerative Medicine Players in Europe
Table 34. Import & Export of Translational Regenerative Medicine in Europe (K Units)
Table 35. Key Translational Regenerative Medicine Players in China
Table 36. Import & Export of Translational Regenerative Medicine in China (K Units)
Table 37. Key Translational Regenerative Medicine Players in Japan
Table 38. Import & Export of Translational Regenerative Medicine in Japan (K Units)
Table 39. Global Translational Regenerative Medicine Consumption by Regions (2015-2020) (K Units)
Table 40. Global Translational Regenerative Medicine Consumption Market Share by Regions (2015-2020)
Table 41. North America Translational Regenerative Medicine Consumption by Application (2015-2020) (K Units)
Table 42. North America Translational Regenerative Medicine Consumption by Countries (2015-2020) (K Units)
Table 43. Europe Translational Regenerative Medicine Consumption by Application (2015-2020) (K Units)
Table 44. Europe Translational Regenerative Medicine Consumption by Countries (2015-2020) (K Units)
Table 45. Asia Pacific Translational Regenerative Medicine Consumption by Application (2015-2020) (K Units)
Table 46. Asia Pacific Translational Regenerative Medicine Consumption Market Share by Application (2015-2020) (K Units)
Table 47. Asia Pacific Translational Regenerative Medicine Consumption by Regions (2015-2020) (K Units)
Table 48. Latin America Translational Regenerative Medicine Consumption by Application (2015-2020) (K Units)
Table 49. Latin America Translational Regenerative Medicine Consumption by Countries (2015-2020) (K Units)
Table 50. Middle East and Africa Translational Regenerative Medicine Consumption by Application (2015-2020) (K Units)
Table 51. Middle East and Africa Translational Regenerative Medicine Consumption by Countries (2015-2020) (K Units)
Table 52. Global Translational Regenerative Medicine Production by Type (2015-2020) (K Units)
Table 53. Global Translational Regenerative Medicine Production Share by Type (2015-2020)
Table 54. Global Translational Regenerative Medicine Revenue by Type (2015-2020) (Million US$)
Table 55. Global Translational Regenerative Medicine Revenue Share by Type (2015-2020)
Table 56. Translational Regenerative Medicine Price by Type 2015-2020 (USD/Unit)
Table 57. Global Translational Regenerative Medicine Consumption by Application (2015-2020) (K Units)
Table 58. Global Translational Regenerative Medicine Consumption by Application (2015-2020) (K Units)
Table 59. Global Translational Regenerative Medicine Consumption Share by Application (2015-2020)
Table 60. Athersys Corporation Information
Table 61. Athersys Description and Major Businesses
Table 62. Athersys Translational Regenerative Medicine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 63. Athersys Product
Table 64. Athersys Recent Development
Table 65. Avita Medical Corporation Information
Table 66. Avita Medical Description and Major Businesses
Table 67. Avita Medical Translational Regenerative Medicine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 68. Avita Medical Product
Table 69. Avita Medical Recent Development
Table 70. AxoGen Corporation Information
Table 71. AxoGen Description and Major Businesses
Table 72. AxoGen Translational Regenerative Medicine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 73. AxoGen Product
Table 74. AxoGen Recent Development
Table 75. MEDIPOST Corporation Information
Table 76. MEDIPOST Description and Major Businesses
Table 77. MEDIPOST Translational Regenerative Medicine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. MEDIPOST Product
Table 79. MEDIPOST Recent Development
Table 80. NuVasive Corporation Information
Table 81. NuVasive Description and Major Businesses
Table 82. NuVasive Translational Regenerative Medicine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. NuVasive Product
Table 84. NuVasive Recent Development
Table 85. Astellas Pharma Corporation Information
Table 86. Astellas Pharma Description and Major Businesses
Table 87. Astellas Pharma Translational Regenerative Medicine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Astellas Pharma Product
Table 89. Astellas Pharma Recent Development
Table 90. Organogenesis Holdings Corporation Information
Table 91. Organogenesis Holdings Description and Major Businesses
Table 92. Organogenesis Holdings Translational Regenerative Medicine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Organogenesis Holdings Product
Table 94. Organogenesis Holdings Recent Development
Table 95. Osiris Therapeutics Corporation Information
Table 96. Osiris Therapeutics Description and Major Businesses
Table 97. Osiris Therapeutics Translational Regenerative Medicine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Osiris Therapeutics Product
Table 99. Osiris Therapeutics Recent Development
Table 100. Pharmicell Corporation Information
Table 101. Pharmicell Description and Major Businesses
Table 102. Pharmicell Translational Regenerative Medicine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Pharmicell Product
Table 104. Pharmicell Recent Development
Table 105. Regenerys Corporation Information
Table 106. Regenerys Description and Major Businesses
Table 107. Regenerys Translational Regenerative Medicine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Regenerys Product
Table 109. Regenerys Recent Development
Table 110. Takeda Pharmaceutical Corporation Information
Table 111. Takeda Pharmaceutical Description and Major Businesses
Table 112. Takeda Pharmaceutical Translational Regenerative Medicine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. Takeda Pharmaceutical Product
Table 114. Takeda Pharmaceutical Recent Development
Table 115. uniQure Corporation Information
Table 116. uniQure Description and Major Businesses
Table 117. uniQure Translational Regenerative Medicine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 118. uniQure Product
Table 119. uniQure Recent Development
Table 120. Vericel Corporation Information
Table 121. Vericel Description and Major Businesses
Table 122. Vericel Translational Regenerative Medicine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 123. Vericel Product
Table 124. Vericel Recent Development
Table 125. Global Translational Regenerative Medicine Revenue Forecast by Region (2021-2026) (Million US$)
Table 126. Global Translational Regenerative Medicine Production Forecast by Regions (2021-2026) (K Units)
Table 127. Global Translational Regenerative Medicine Production Forecast by Type (2021-2026) (K Units)
Table 128. Global Translational Regenerative Medicine Revenue Forecast by Type (2021-2026) (Million US$)
Table 129. North America Translational Regenerative Medicine Consumption Forecast by Regions (2021-2026) (K Units)
Table 130. Europe Translational Regenerative Medicine Consumption Forecast by Regions (2021-2026) (K Units)
Table 131. Asia Pacific Translational Regenerative Medicine Consumption Forecast by Regions (2021-2026) (K Units)
Table 132. Latin America Translational Regenerative Medicine Consumption Forecast by Regions (2021-2026) (K Units)
Table 133. Middle East and Africa Translational Regenerative Medicine Consumption Forecast by Regions (2021-2026) (K Units)
Table 134. Translational Regenerative Medicine Distributors List
Table 135. Translational Regenerative Medicine Customers List
Table 136. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 137. Key Challenges
Table 138. Market Risks
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
Table 1. Translational Regenerative Medicine Key Market Segments in This Study
Table 2. Ranking of Global Top Translational Regenerative Medicine Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Translational Regenerative Medicine Market Size Growth Rate by Type 2020-2026 (K Units) (Million US$)
Table 4. Major Manufacturers of Stem Cell Therapy
Table 5. Major Manufacturers of Tissue Engineering
Table 6. Major Manufacturers of Gene Therapy
Table 7. COVID-19 Impact Global Market: (Four Translational Regenerative Medicine Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Translational Regenerative Medicine Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Translational Regenerative Medicine Players to Combat Covid-19 Impact
Table 12. Global Translational Regenerative Medicine Market Size Growth Rate by Application 2020-2026 (K Units)
Table 13. Global Translational Regenerative Medicine Market Size by Region in US$ Million: 2015 VS 2020 VS 2026
Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Global Translational Regenerative Medicine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Translational Regenerative Medicine as of 2019)
Table 16. Translational Regenerative Medicine Manufacturing Base Distribution and Headquarters
Table 17. Manufacturers Translational Regenerative Medicine Product Offered
Table 18. Date of Manufacturers Enter into Translational Regenerative Medicine Market
Table 19. Key Trends for Translational Regenerative Medicine Markets & Products
Table 20. Main Points Interviewed from Key Translational Regenerative Medicine Players
Table 21. Global Translational Regenerative Medicine Production Capacity by Manufacturers (2015-2020) (K Units)
Table 22. Global Translational Regenerative Medicine Production Share by Manufacturers (2015-2020)
Table 23. Translational Regenerative Medicine Revenue by Manufacturers (2015-2020) (Million US$)
Table 24. Translational Regenerative Medicine Revenue Share by Manufacturers (2015-2020)
Table 25. Translational Regenerative Medicine Price by Manufacturers 2015-2020 (USD/Unit)
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Translational Regenerative Medicine Production by Regions (2015-2020) (K Units)
Table 28. Global Translational Regenerative Medicine Production Market Share by Regions (2015-2020)
Table 29. Global Translational Regenerative Medicine Revenue by Regions (2015-2020) (US$ Million)
Table 30. Global Translational Regenerative Medicine Revenue Market Share by Regions (2015-2020)
Table 31. Key Translational Regenerative Medicine Players in North America
Table 32. Import & Export of Translational Regenerative Medicine in North America (K Units)
Table 33. Key Translational Regenerative Medicine Players in Europe
Table 34. Import & Export of Translational Regenerative Medicine in Europe (K Units)
Table 35. Key Translational Regenerative Medicine Players in China
Table 36. Import & Export of Translational Regenerative Medicine in China (K Units)
Table 37. Key Translational Regenerative Medicine Players in Japan
Table 38. Import & Export of Translational Regenerative Medicine in Japan (K Units)
Table 39. Global Translational Regenerative Medicine Consumption by Regions (2015-2020) (K Units)
Table 40. Global Translational Regenerative Medicine Consumption Market Share by Regions (2015-2020)
Table 41. North America Translational Regenerative Medicine Consumption by Application (2015-2020) (K Units)
Table 42. North America Translational Regenerative Medicine Consumption by Countries (2015-2020) (K Units)
Table 43. Europe Translational Regenerative Medicine Consumption by Application (2015-2020) (K Units)
Table 44. Europe Translational Regenerative Medicine Consumption by Countries (2015-2020) (K Units)
Table 45. Asia Pacific Translational Regenerative Medicine Consumption by Application (2015-2020) (K Units)
Table 46. Asia Pacific Translational Regenerative Medicine Consumption Market Share by Application (2015-2020) (K Units)
Table 47. Asia Pacific Translational Regenerative Medicine Consumption by Regions (2015-2020) (K Units)
Table 48. Latin America Translational Regenerative Medicine Consumption by Application (2015-2020) (K Units)
Table 49. Latin America Translational Regenerative Medicine Consumption by Countries (2015-2020) (K Units)
Table 50. Middle East and Africa Translational Regenerative Medicine Consumption by Application (2015-2020) (K Units)
Table 51. Middle East and Africa Translational Regenerative Medicine Consumption by Countries (2015-2020) (K Units)
Table 52. Global Translational Regenerative Medicine Production by Type (2015-2020) (K Units)
Table 53. Global Translational Regenerative Medicine Production Share by Type (2015-2020)
Table 54. Global Translational Regenerative Medicine Revenue by Type (2015-2020) (Million US$)
Table 55. Global Translational Regenerative Medicine Revenue Share by Type (2015-2020)
Table 56. Translational Regenerative Medicine Price by Type 2015-2020 (USD/Unit)
Table 57. Global Translational Regenerative Medicine Consumption by Application (2015-2020) (K Units)
Table 58. Global Translational Regenerative Medicine Consumption by Application (2015-2020) (K Units)
Table 59. Global Translational Regenerative Medicine Consumption Share by Application (2015-2020)
Table 60. Athersys Corporation Information
Table 61. Athersys Description and Major Businesses
Table 62. Athersys Translational Regenerative Medicine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 63. Athersys Product
Table 64. Athersys Recent Development
Table 65. Avita Medical Corporation Information
Table 66. Avita Medical Description and Major Businesses
Table 67. Avita Medical Translational Regenerative Medicine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 68. Avita Medical Product
Table 69. Avita Medical Recent Development
Table 70. AxoGen Corporation Information
Table 71. AxoGen Description and Major Businesses
Table 72. AxoGen Translational Regenerative Medicine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 73. AxoGen Product
Table 74. AxoGen Recent Development
Table 75. MEDIPOST Corporation Information
Table 76. MEDIPOST Description and Major Businesses
Table 77. MEDIPOST Translational Regenerative Medicine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. MEDIPOST Product
Table 79. MEDIPOST Recent Development
Table 80. NuVasive Corporation Information
Table 81. NuVasive Description and Major Businesses
Table 82. NuVasive Translational Regenerative Medicine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. NuVasive Product
Table 84. NuVasive Recent Development
Table 85. Astellas Pharma Corporation Information
Table 86. Astellas Pharma Description and Major Businesses
Table 87. Astellas Pharma Translational Regenerative Medicine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Astellas Pharma Product
Table 89. Astellas Pharma Recent Development
Table 90. Organogenesis Holdings Corporation Information
Table 91. Organogenesis Holdings Description and Major Businesses
Table 92. Organogenesis Holdings Translational Regenerative Medicine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Organogenesis Holdings Product
Table 94. Organogenesis Holdings Recent Development
Table 95. Osiris Therapeutics Corporation Information
Table 96. Osiris Therapeutics Description and Major Businesses
Table 97. Osiris Therapeutics Translational Regenerative Medicine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Osiris Therapeutics Product
Table 99. Osiris Therapeutics Recent Development
Table 100. Pharmicell Corporation Information
Table 101. Pharmicell Description and Major Businesses
Table 102. Pharmicell Translational Regenerative Medicine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Pharmicell Product
Table 104. Pharmicell Recent Development
Table 105. Regenerys Corporation Information
Table 106. Regenerys Description and Major Businesses
Table 107. Regenerys Translational Regenerative Medicine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Regenerys Product
Table 109. Regenerys Recent Development
Table 110. Takeda Pharmaceutical Corporation Information
Table 111. Takeda Pharmaceutical Description and Major Businesses
Table 112. Takeda Pharmaceutical Translational Regenerative Medicine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. Takeda Pharmaceutical Product
Table 114. Takeda Pharmaceutical Recent Development
Table 115. uniQure Corporation Information
Table 116. uniQure Description and Major Businesses
Table 117. uniQure Translational Regenerative Medicine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 118. uniQure Product
Table 119. uniQure Recent Development
Table 120. Vericel Corporation Information
Table 121. Vericel Description and Major Businesses
Table 122. Vericel Translational Regenerative Medicine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 123. Vericel Product
Table 124. Vericel Recent Development
Table 125. Global Translational Regenerative Medicine Revenue Forecast by Region (2021-2026) (Million US$)
Table 126. Global Translational Regenerative Medicine Production Forecast by Regions (2021-2026) (K Units)
Table 127. Global Translational Regenerative Medicine Production Forecast by Type (2021-2026) (K Units)
Table 128. Global Translational Regenerative Medicine Revenue Forecast by Type (2021-2026) (Million US$)
Table 129. North America Translational Regenerative Medicine Consumption Forecast by Regions (2021-2026) (K Units)
Table 130. Europe Translational Regenerative Medicine Consumption Forecast by Regions (2021-2026) (K Units)
Table 131. Asia Pacific Translational Regenerative Medicine Consumption Forecast by Regions (2021-2026) (K Units)
Table 132. Latin America Translational Regenerative Medicine Consumption Forecast by Regions (2021-2026) (K Units)
Table 133. Middle East and Africa Translational Regenerative Medicine Consumption Forecast by Regions (2021-2026) (K Units)
Table 134. Translational Regenerative Medicine Distributors List
Table 135. Translational Regenerative Medicine Customers List
Table 136. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 137. Key Challenges
Table 138. Market Risks
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Translational Regenerative Medicine Product Picture
Figure 2. Global Translational Regenerative Medicine Production Market Share by Type in 2020 & 2026
Figure 3. Stem Cell Therapy Product Picture
Figure 4. Tissue Engineering Product Picture
Figure 5. Gene Therapy Product Picture
Figure 6. Global Translational Regenerative Medicine Consumption Market Share by Application in 2020 & 2026
Figure 7. Tissue Engineering Therapy
Figure 8. Wound Healing
Figure 9. Cartilage Repair
Figure 10. Other
Figure 11. Translational Regenerative Medicine Report Years Considered
Figure 12. Global Translational Regenerative Medicine Revenue 2015-2026 (Million US$)
Figure 13. Global Translational Regenerative Medicine Production Capacity 2015-2026 (K Units)
Figure 14. Global Translational Regenerative Medicine Production 2015-2026 (K Units)
Figure 15. Global Translational Regenerative Medicine Market Share Scenario by Region in Percentage: 2020 Versus 2026
Figure 16. Translational Regenerative Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 17. Global Translational Regenerative Medicine Production Share by Manufacturers in 2015
Figure 18. The Top 10 and Top 5 Players Market Share by Translational Regenerative Medicine Revenue in 2019
Figure 19. Global Translational Regenerative Medicine Production Market Share by Region (2015-2020)
Figure 20. Translational Regenerative Medicine Production Growth Rate in North America (2015-2020) (K Units)
Figure 21. Translational Regenerative Medicine Revenue Growth Rate in North America (2015-2020) (US$ Million)
Figure 22. Translational Regenerative Medicine Production Growth Rate in Europe (2015-2020) (K Units)
Figure 23. Translational Regenerative Medicine Revenue Growth Rate in Europe (2015-2020) (US$ Million)
Figure 24. Translational Regenerative Medicine Production Growth Rate in China (2015-2020) (K Units)
Figure 25. Translational Regenerative Medicine Revenue Growth Rate in China (2015-2020) (US$ Million)
Figure 26. Translational Regenerative Medicine Production Growth Rate in Japan (2015-2020) (K Units)
Figure 27. Translational Regenerative Medicine Revenue Growth Rate in Japan (2015-2020) (US$ Million)
Figure 28. Global Translational Regenerative Medicine Consumption Market Share by Regions 2015-2020
Figure 29. North America Translational Regenerative Medicine Consumption and Growth Rate (2015-2020) (K Units)
Figure 30. North America Translational Regenerative Medicine Consumption Market Share by Application in 2019
Figure 31. North America Translational Regenerative Medicine Consumption Market Share by Countries in 2019
Figure 32. U.S. Translational Regenerative Medicine Consumption and Growth Rate (2015-2020) (K Units)
Figure 33. Canada Translational Regenerative Medicine Consumption and Growth Rate (2015-2020) (K Units)
Figure 34. Europe Translational Regenerative Medicine Consumption and Growth Rate (2015-2020) (K Units)
Figure 35. Europe Translational Regenerative Medicine Consumption Market Share by Application in 2019
Figure 36. Europe Translational Regenerative Medicine Consumption Market Share by Countries in 2019
Figure 37. Germany Translational Regenerative Medicine Consumption and Growth Rate (2015-2020) (K Units)
Figure 38. France Translational Regenerative Medicine Consumption and Growth Rate (2015-2020) (K Units)
Figure 39. U.K. Translational Regenerative Medicine Consumption and Growth Rate (2015-2020) (K Units)
Figure 40. Italy Translational Regenerative Medicine Consumption and Growth Rate (2015-2020) (K Units)
Figure 41. Russia Translational Regenerative Medicine Consumption and Growth Rate (2015-2020) (K Units)
Figure 42. Asia Pacific Translational Regenerative Medicine Consumption and Growth Rate (K Units)
Figure 43. Asia Pacific Translational Regenerative Medicine Consumption Market Share by Application in 2019
Figure 44. Asia Pacific Translational Regenerative Medicine Consumption Market Share by Regions in 2019
Figure 45. China Translational Regenerative Medicine Consumption and Growth Rate (2015-2020) (K Units)
Figure 46. Japan Translational Regenerative Medicine Consumption and Growth Rate (2015-2020) (K Units)
Figure 47. South Korea Translational Regenerative Medicine Consumption and Growth Rate (2015-2020) (K Units)
Figure 48. India Translational Regenerative Medicine Consumption and Growth Rate (2015-2020) (K Units)
Figure 49. Australia Translational Regenerative Medicine Consumption and Growth Rate (2015-2020) (K Units)
Figure 50. Taiwan Translational Regenerative Medicine Consumption and Growth Rate (2015-2020) (K Units)
Figure 51. Indonesia Translational Regenerative Medicine Consumption and Growth Rate (2015-2020) (K Units)
Figure 52. Thailand Translational Regenerative Medicine Consumption and Growth Rate (2015-2020) (K Units)
Figure 53. Malaysia Translational Regenerative Medicine Consumption and Growth Rate (2015-2020) (K Units)
Figure 54. Philippines Translational Regenerative Medicine Consumption and Growth Rate (2015-2020) (K Units)
Figure 55. Vietnam Translational Regenerative Medicine Consumption and Growth Rate (2015-2020) (K Units)
Figure 56. Latin America Translational Regenerative Medicine Consumption and Growth Rate (K Units)
Figure 57. Latin America Translational Regenerative Medicine Consumption Market Share by Application in 2019
Figure 58. Latin America Translational Regenerative Medicine Consumption Market Share by Countries in 2019
Figure 59. Mexico Translational Regenerative Medicine Consumption and Growth Rate (2015-2020) (K Units)
Figure 60. Brazil Translational Regenerative Medicine Consumption and Growth Rate (2015-2020) (K Units)
Figure 61. Argentina Translational Regenerative Medicine Consumption and Growth Rate (2015-2020) (K Units)
Figure 62. Middle East and Africa Translational Regenerative Medicine Consumption and Growth Rate (K Units)
Figure 63. Middle East and Africa Translational Regenerative Medicine Consumption Market Share by Application in 2019
Figure 64. Middle East and Africa Translational Regenerative Medicine Consumption Market Share by Countries in 2019
Figure 65. Turkey Translational Regenerative Medicine Consumption and Growth Rate (2015-2020) (K Units)
Figure 66. Saudi Arabia Translational Regenerative Medicine Consumption and Growth Rate (2015-2020) (K Units)
Figure 67. U.A.E Translational Regenerative Medicine Consumption and Growth Rate (2015-2020) (K Units)
Figure 68. Global Translational Regenerative Medicine Production Market Share by Type (2015-2020)
Figure 69. Global Translational Regenerative Medicine Production Market Share by Type in 2019
Figure 70. Global Translational Regenerative Medicine Revenue Market Share by Type (2015-2020)
Figure 71. Global Translational Regenerative Medicine Revenue Market Share by Type in 2019
Figure 72. Global Translational Regenerative Medicine Production Market Share Forecast by Type (2021-2026)
Figure 73. Global Translational Regenerative Medicine Revenue Market Share Forecast by Type (2021-2026)
Figure 74. Global Translational Regenerative Medicine Market Share by Price Range (2015-2020)
Figure 75. Global Translational Regenerative Medicine Consumption Market Share by Application (2015-2020)
Figure 76. Global Translational Regenerative Medicine Value (Consumption) Market Share by Application (2015-2020)
Figure 77. Global Translational Regenerative Medicine Consumption Market Share Forecast by Application (2021-2026)
Figure 78. Athersys Total Revenue (US$ Million): 2019 Compared with 2018
Figure 79. Avita Medical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 80. AxoGen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 81. MEDIPOST Total Revenue (US$ Million): 2019 Compared with 2018
Figure 82. NuVasive Total Revenue (US$ Million): 2019 Compared with 2018
Figure 83. Astellas Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 84. Organogenesis Holdings Total Revenue (US$ Million): 2019 Compared with 2018
Figure 85. Osiris Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 86. Pharmicell Total Revenue (US$ Million): 2019 Compared with 2018
Figure 87. Regenerys Total Revenue (US$ Million): 2019 Compared with 2018
Figure 88. Takeda Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. uniQure Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Vericel Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Global Translational Regenerative Medicine Revenue Forecast by Regions (2021-2026) (US$ Million)
Figure 92. Global Translational Regenerative Medicine Revenue Market Share Forecast by Regions ((2021-2026))
Figure 93. Global Translational Regenerative Medicine Production Forecast by Regions (2021-2026) (K Units)
Figure 94. North America Translational Regenerative Medicine Production Forecast (2021-2026) (K Units)
Figure 95. North America Translational Regenerative Medicine Revenue Forecast (2021-2026) (US$ Million)
Figure 96. Europe Translational Regenerative Medicine Production Forecast (2021-2026) (K Units)
Figure 97. Europe Translational Regenerative Medicine Revenue Forecast (2021-2026) (US$ Million)
Figure 98. China Translational Regenerative Medicine Production Forecast (2021-2026) (K Units)
Figure 99. China Translational Regenerative Medicine Revenue Forecast (2021-2026) (US$ Million)
Figure 100. Japan Translational Regenerative Medicine Production Forecast (2021-2026) (K Units)
Figure 101. Japan Translational Regenerative Medicine Revenue Forecast (2021-2026) (US$ Million)
Figure 102. Global Translational Regenerative Medicine Consumption Market Share Forecast by Region (2021-2026)
Figure 103. Translational Regenerative Medicine Value Chain
Figure 104. Channels of Distribution
Figure 105. Distributors Profiles
Figure 106. Porter's Five Forces Analysis
Figure 107. Bottom-up and Top-down Approaches for This Report
Figure 108. Data Triangulation
Figure 109. Key Executives Interviewed
Figure 1. Translational Regenerative Medicine Product Picture
Figure 2. Global Translational Regenerative Medicine Production Market Share by Type in 2020 & 2026
Figure 3. Stem Cell Therapy Product Picture
Figure 4. Tissue Engineering Product Picture
Figure 5. Gene Therapy Product Picture
Figure 6. Global Translational Regenerative Medicine Consumption Market Share by Application in 2020 & 2026
Figure 7. Tissue Engineering Therapy
Figure 8. Wound Healing
Figure 9. Cartilage Repair
Figure 10. Other
Figure 11. Translational Regenerative Medicine Report Years Considered
Figure 12. Global Translational Regenerative Medicine Revenue 2015-2026 (Million US$)
Figure 13. Global Translational Regenerative Medicine Production Capacity 2015-2026 (K Units)
Figure 14. Global Translational Regenerative Medicine Production 2015-2026 (K Units)
Figure 15. Global Translational Regenerative Medicine Market Share Scenario by Region in Percentage: 2020 Versus 2026
Figure 16. Translational Regenerative Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 17. Global Translational Regenerative Medicine Production Share by Manufacturers in 2015
Figure 18. The Top 10 and Top 5 Players Market Share by Translational Regenerative Medicine Revenue in 2019
Figure 19. Global Translational Regenerative Medicine Production Market Share by Region (2015-2020)
Figure 20. Translational Regenerative Medicine Production Growth Rate in North America (2015-2020) (K Units)
Figure 21. Translational Regenerative Medicine Revenue Growth Rate in North America (2015-2020) (US$ Million)
Figure 22. Translational Regenerative Medicine Production Growth Rate in Europe (2015-2020) (K Units)
Figure 23. Translational Regenerative Medicine Revenue Growth Rate in Europe (2015-2020) (US$ Million)
Figure 24. Translational Regenerative Medicine Production Growth Rate in China (2015-2020) (K Units)
Figure 25. Translational Regenerative Medicine Revenue Growth Rate in China (2015-2020) (US$ Million)
Figure 26. Translational Regenerative Medicine Production Growth Rate in Japan (2015-2020) (K Units)
Figure 27. Translational Regenerative Medicine Revenue Growth Rate in Japan (2015-2020) (US$ Million)
Figure 28. Global Translational Regenerative Medicine Consumption Market Share by Regions 2015-2020
Figure 29. North America Translational Regenerative Medicine Consumption and Growth Rate (2015-2020) (K Units)
Figure 30. North America Translational Regenerative Medicine Consumption Market Share by Application in 2019
Figure 31. North America Translational Regenerative Medicine Consumption Market Share by Countries in 2019
Figure 32. U.S. Translational Regenerative Medicine Consumption and Growth Rate (2015-2020) (K Units)
Figure 33. Canada Translational Regenerative Medicine Consumption and Growth Rate (2015-2020) (K Units)
Figure 34. Europe Translational Regenerative Medicine Consumption and Growth Rate (2015-2020) (K Units)
Figure 35. Europe Translational Regenerative Medicine Consumption Market Share by Application in 2019
Figure 36. Europe Translational Regenerative Medicine Consumption Market Share by Countries in 2019
Figure 37. Germany Translational Regenerative Medicine Consumption and Growth Rate (2015-2020) (K Units)
Figure 38. France Translational Regenerative Medicine Consumption and Growth Rate (2015-2020) (K Units)
Figure 39. U.K. Translational Regenerative Medicine Consumption and Growth Rate (2015-2020) (K Units)
Figure 40. Italy Translational Regenerative Medicine Consumption and Growth Rate (2015-2020) (K Units)
Figure 41. Russia Translational Regenerative Medicine Consumption and Growth Rate (2015-2020) (K Units)
Figure 42. Asia Pacific Translational Regenerative Medicine Consumption and Growth Rate (K Units)
Figure 43. Asia Pacific Translational Regenerative Medicine Consumption Market Share by Application in 2019
Figure 44. Asia Pacific Translational Regenerative Medicine Consumption Market Share by Regions in 2019
Figure 45. China Translational Regenerative Medicine Consumption and Growth Rate (2015-2020) (K Units)
Figure 46. Japan Translational Regenerative Medicine Consumption and Growth Rate (2015-2020) (K Units)
Figure 47. South Korea Translational Regenerative Medicine Consumption and Growth Rate (2015-2020) (K Units)
Figure 48. India Translational Regenerative Medicine Consumption and Growth Rate (2015-2020) (K Units)
Figure 49. Australia Translational Regenerative Medicine Consumption and Growth Rate (2015-2020) (K Units)
Figure 50. Taiwan Translational Regenerative Medicine Consumption and Growth Rate (2015-2020) (K Units)
Figure 51. Indonesia Translational Regenerative Medicine Consumption and Growth Rate (2015-2020) (K Units)
Figure 52. Thailand Translational Regenerative Medicine Consumption and Growth Rate (2015-2020) (K Units)
Figure 53. Malaysia Translational Regenerative Medicine Consumption and Growth Rate (2015-2020) (K Units)
Figure 54. Philippines Translational Regenerative Medicine Consumption and Growth Rate (2015-2020) (K Units)
Figure 55. Vietnam Translational Regenerative Medicine Consumption and Growth Rate (2015-2020) (K Units)
Figure 56. Latin America Translational Regenerative Medicine Consumption and Growth Rate (K Units)
Figure 57. Latin America Translational Regenerative Medicine Consumption Market Share by Application in 2019
Figure 58. Latin America Translational Regenerative Medicine Consumption Market Share by Countries in 2019
Figure 59. Mexico Translational Regenerative Medicine Consumption and Growth Rate (2015-2020) (K Units)
Figure 60. Brazil Translational Regenerative Medicine Consumption and Growth Rate (2015-2020) (K Units)
Figure 61. Argentina Translational Regenerative Medicine Consumption and Growth Rate (2015-2020) (K Units)
Figure 62. Middle East and Africa Translational Regenerative Medicine Consumption and Growth Rate (K Units)
Figure 63. Middle East and Africa Translational Regenerative Medicine Consumption Market Share by Application in 2019
Figure 64. Middle East and Africa Translational Regenerative Medicine Consumption Market Share by Countries in 2019
Figure 65. Turkey Translational Regenerative Medicine Consumption and Growth Rate (2015-2020) (K Units)
Figure 66. Saudi Arabia Translational Regenerative Medicine Consumption and Growth Rate (2015-2020) (K Units)
Figure 67. U.A.E Translational Regenerative Medicine Consumption and Growth Rate (2015-2020) (K Units)
Figure 68. Global Translational Regenerative Medicine Production Market Share by Type (2015-2020)
Figure 69. Global Translational Regenerative Medicine Production Market Share by Type in 2019
Figure 70. Global Translational Regenerative Medicine Revenue Market Share by Type (2015-2020)
Figure 71. Global Translational Regenerative Medicine Revenue Market Share by Type in 2019
Figure 72. Global Translational Regenerative Medicine Production Market Share Forecast by Type (2021-2026)
Figure 73. Global Translational Regenerative Medicine Revenue Market Share Forecast by Type (2021-2026)
Figure 74. Global Translational Regenerative Medicine Market Share by Price Range (2015-2020)
Figure 75. Global Translational Regenerative Medicine Consumption Market Share by Application (2015-2020)
Figure 76. Global Translational Regenerative Medicine Value (Consumption) Market Share by Application (2015-2020)
Figure 77. Global Translational Regenerative Medicine Consumption Market Share Forecast by Application (2021-2026)
Figure 78. Athersys Total Revenue (US$ Million): 2019 Compared with 2018
Figure 79. Avita Medical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 80. AxoGen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 81. MEDIPOST Total Revenue (US$ Million): 2019 Compared with 2018
Figure 82. NuVasive Total Revenue (US$ Million): 2019 Compared with 2018
Figure 83. Astellas Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 84. Organogenesis Holdings Total Revenue (US$ Million): 2019 Compared with 2018
Figure 85. Osiris Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 86. Pharmicell Total Revenue (US$ Million): 2019 Compared with 2018
Figure 87. Regenerys Total Revenue (US$ Million): 2019 Compared with 2018
Figure 88. Takeda Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. uniQure Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Vericel Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Global Translational Regenerative Medicine Revenue Forecast by Regions (2021-2026) (US$ Million)
Figure 92. Global Translational Regenerative Medicine Revenue Market Share Forecast by Regions ((2021-2026))
Figure 93. Global Translational Regenerative Medicine Production Forecast by Regions (2021-2026) (K Units)
Figure 94. North America Translational Regenerative Medicine Production Forecast (2021-2026) (K Units)
Figure 95. North America Translational Regenerative Medicine Revenue Forecast (2021-2026) (US$ Million)
Figure 96. Europe Translational Regenerative Medicine Production Forecast (2021-2026) (K Units)
Figure 97. Europe Translational Regenerative Medicine Revenue Forecast (2021-2026) (US$ Million)
Figure 98. China Translational Regenerative Medicine Production Forecast (2021-2026) (K Units)
Figure 99. China Translational Regenerative Medicine Revenue Forecast (2021-2026) (US$ Million)
Figure 100. Japan Translational Regenerative Medicine Production Forecast (2021-2026) (K Units)
Figure 101. Japan Translational Regenerative Medicine Revenue Forecast (2021-2026) (US$ Million)
Figure 102. Global Translational Regenerative Medicine Consumption Market Share Forecast by Region (2021-2026)
Figure 103. Translational Regenerative Medicine Value Chain
Figure 104. Channels of Distribution
Figure 105. Distributors Profiles
Figure 106. Porter's Five Forces Analysis
Figure 107. Bottom-up and Top-down Approaches for This Report
Figure 108. Data Triangulation
Figure 109. Key Executives Interviewed
